Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THAILAND POINT-OF-CARE-TESTING (POCT) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE THAILAND POINT-OF-CARE-TESTING (POCT) SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET : RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 OPPUTUNITY MAP ANALYSIS
13 HEALTHCARE ECONOMY
13.1 HEALTHCARE EXPENDITURE
13.2 CAPITAL EXPENDITURE
13.3 CAPEX TRENDS
13.4 CAPEX ALLOCATION
13.5 FUNDING SOURCES
13.6 INDUSTRY BENCHMARKS
13.7 GDP RATION IN OVERALL GDP
13.8 HEALTHCARE SYSTEM STRUCTURE
13.9 GOVERNMENT POLICIES
13.1 ECONOMIC DEVELOPMENT
14 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , BY PRODUCT TYPE
14.1 OVERVIEW
14.2 CARDIOMETABOLIC MONITORING PRODUCTS
14.2.1 CARDIAC MARKER TESTING PRODUCTS
14.2.1.1. HSTNL
14.2.1.1.1. MARKET VALUE (USD MILLION)
14.2.1.1.2. MARKET VOLUME (UNITS)
14.2.1.1.3. AVERAGE SELLING PRICE (USD)
14.2.1.2. BNP
14.2.1.2.1. MARKET VALUE (USD MILLION)
14.2.1.2.2. MARKET VOLUME (UNITS)
14.2.1.2.3. AVERAGE SELLING PRICE (USD)
14.2.1.3. D-DIMER
14.2.1.3.1. MARKET VALUE (USD MILLION)
14.2.1.3.2. MARKET VOLUME (UNITS)
14.2.1.3.3. AVERAGE SELLING PRICE (USD)
14.2.1.4. CK-MB
14.2.1.4.1. MARKET VALUE (USD MILLION)
14.2.1.4.2. MARKET VOLUME (UNITS)
14.2.1.4.3. AVERAGE SELLING PRICE (USD)
14.2.1.5. MYOGLOBIN
14.2.1.5.1. MARKET VALUE (USD MILLION)
14.2.1.5.2. MARKET VOLUME (UNITS)
14.2.1.5.3. AVERAGE SELLING PRICE (USD)
14.2.1.6. OTHERS
14.2.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
14.2.2.1. BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES
14.2.2.1.1. CARTRIDGES
14.2.2.1.1.1 MARKET VALUE (USD MILLION)
14.2.2.1.1.2 MARKET VOLUME (UNITS)
14.2.2.1.1.3 AVERAGE SELLING PRICE (USD)
14.2.2.1.2. REAGENTS
14.2.2.1.2.1 MARKET VALUE (USD MILLION)
14.2.2.1.2.2 MARKET VOLUME (UNITS)
14.2.2.1.2.3 AVERAGE SELLING PRICE (USD)
14.2.2.2. BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS
14.2.2.2.1. BENCHTOP
14.2.2.2.1.1 BLOOD GAS ANALYZERS
14.2.2.2.1.1.1. MARKET VALUE (USD MILLION)
14.2.2.2.1.1.2. MARKET VOLUME (UNITS)
14.2.2.2.1.1.3. AVERAGE SELLING PRICE (USD)
14.2.2.2.1.2 ELECTROLYTE ANALYZERS
14.2.2.2.1.2.1. MARKET VALUE (USD MILLION)
14.2.2.2.1.2.2. MARKET VOLUME (UNITS)
14.2.2.2.1.2.3. AVERAGE SELLING PRICE (USD)
14.2.2.2.1.3 COMBINED ANALYZERS
14.2.2.2.1.3.1. MARKET VALUE (USD MILLION)
14.2.2.2.1.3.2. MARKET VOLUME (UNITS)
14.2.2.2.1.3.3. AVERAGE SELLING PRICE (USD)
14.2.2.2.2. PORTABLE
14.2.2.2.2.1 BLOOD GAS ANALYZERS
14.2.2.2.2.1.1. MARKET VALUE (USD MILLION)
14.2.2.2.2.1.2. MARKET VOLUME (UNITS)
14.2.2.2.2.1.3. AVERAGE SELLING PRICE (USD)
14.2.2.2.2.2 ELECTROLYTE ANALYZERS
14.2.2.2.2.2.1. MARKET VALUE (USD MILLION)
14.2.2.2.2.2.2. MARKET VOLUME (UNITS)
14.2.2.2.2.2.3. AVERAGE SELLING PRICE (USD)
14.2.2.2.2.3 COMBINED ANALYZERS
14.2.2.2.2.3.1. MARKET VALUE (USD MILLION)
14.2.2.2.2.3.2. MARKET VOLUME (UNITS)
14.2.2.2.2.3.3. AVERAGE SELLING PRICE (USD)
14.2.3 HBA1C TESTING PRODUCTS
14.2.3.1. HBA1C TESTING INSTRUMENTS
14.2.3.1.1. MARKET VALUE (USD MILLION)
14.2.3.1.2. MARKET VOLUME (UNITS)
14.2.3.1.3. AVERAGE SELLING PRICE (USD)
14.2.3.2. HBA1C TESTING CONSUMABLES
14.2.3.2.1. MARKET VALUE (USD MILLION)
14.2.3.2.2. MARKET VOLUME (UNITS)
14.2.3.2.3. AVERAGE SELLING PRICE (USD)
14.2.4 POC ANALYSER
14.2.4.1. MARKET VALUE (USD MILLION)
14.2.4.2. MARKET VOLUME (UNITS)
14.2.4.3. AVERAGE SELLING PRICE (USD)
14.2.5 ECG DEVICE
14.2.5.1. RESTING ECG DEVICES
14.2.5.1.1. MARKET VALUE (USD MILLION)
14.2.5.1.2. MARKET VOLUME (UNITS)
14.2.5.1.3. AVERAGE SELLING PRICE (USD)
14.2.5.2. STRESS ECG DEVICES
14.2.5.2.1. MARKET VALUE (USD MILLION)
14.2.5.2.2. MARKET VOLUME (UNITS)
14.2.5.2.3. AVERAGE SELLING PRICE (USD)
14.2.5.3. HOLTER MONITORS
14.2.5.3.1. MARKET VALUE (USD MILLION)
14.2.5.3.2. MARKET VOLUME (UNITS)
14.2.5.3.3. AVERAGE SELLING PRICE (USD)
14.2.6 OTHERS
14.3 GLUCOSE MONITORING PRODUCTS
14.3.1 STRIPS
14.3.1.1. MARKET VALUE (USD MILLION)
14.3.1.2. MARKET VOLUME (UNITS)
14.3.1.3. AVERAGE SELLING PRICE (USD)
14.3.2 METERS
14.3.2.1. MARKET VALUE (USD MILLION)
14.3.2.2. MARKET VOLUME (UNITS)
14.3.2.3. AVERAGE SELLING PRICE (USD)
14.3.3 LANCETS & LANCING DEVICES
14.3.3.1. MARKET VALUE (USD MILLION)
14.3.3.2. MARKET VOLUME (UNITS)
14.3.3.3. AVERAGE SELLING PRICE (USD)
14.4 INFECTIOUS DISEASE TESTING PRODUCTS
14.4.1 INFLUENZA TESTING PRODUCTS
14.4.1.1. TRADITIONAL DIAGNOSTIC TEST
14.4.1.1.1. RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)
14.4.1.1.1.1 MARKET VALUE (USD MILLION)
14.4.1.1.1.2 MARKET VOLUME (UNITS)
14.4.1.1.1.3 AVERAGE SELLING PRICE (USD)
14.4.1.1.2. DIRECT FLUORESCENT ANTIBODY TEST (DFAT)
14.4.1.1.2.1 MARKET VALUE (USD MILLION)
14.4.1.1.2.2 MARKET VOLUME (UNITS)
14.4.1.1.2.3 AVERAGE SELLING PRICE (USD)
14.4.1.1.3. VIRAL CULTURE
14.4.1.1.3.1 MARKET VALUE (USD MILLION)
14.4.1.1.3.2 MARKET VOLUME (UNITS)
14.4.1.1.3.3 AVERAGE SELLING PRICE (USD)
14.4.1.1.4. SEROLOGICAL ASSAY
14.4.1.1.4.1 MARKET VALUE (USD MILLION)
14.4.1.1.4.2 MARKET VOLUME (UNITS)
14.4.1.1.4.3 AVERAGE SELLING PRICE (USD)
14.4.1.2. MOLECULAR DIAGNOSTIC ASSAY
14.4.1.2.1. RT-PCR
14.4.1.2.1.1 MARKET VALUE (USD MILLION)
14.4.1.2.1.2 MARKET VOLUME (UNITS)
14.4.1.2.1.3 AVERAGE SELLING PRICE (USD)
14.4.1.2.2. LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)
14.4.1.2.2.1 MARKET VALUE (USD MILLION)
14.4.1.2.2.2 MARKET VOLUME (UNITS)
14.4.1.2.2.3 AVERAGE SELLING PRICE (USD)
14.4.1.2.3. NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)
14.4.1.2.3.1 MARKET VALUE (USD MILLION)
14.4.1.2.3.2 MARKET VOLUME (UNITS)
14.4.1.2.3.3 AVERAGE SELLING PRICE (USD)
14.4.1.2.4. SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)
14.4.1.2.4.1 MARKET VALUE (USD MILLION)
14.4.1.2.4.2 MARKET VOLUME (UNITS)
14.4.1.2.4.3 AVERAGE SELLING PRICE (USD)
14.4.1.2.5. OTHERS
14.4.2 HIV TESTING PRODUCTS
14.4.2.1. TESTING EQUIPMENT
14.4.2.1.1. MARKET VALUE (USD MILLION)
14.4.2.1.2. MARKET VOLUME (UNITS)
14.4.2.1.3. AVERAGE SELLING PRICE (USD)
14.4.2.2. TESTING REAGENT
14.4.2.2.1. MARKET VALUE (USD MILLION)
14.4.2.2.2. MARKET VOLUME (UNITS)
14.4.2.2.3. AVERAGE SELLING PRICE (USD)
14.4.3 HEPATITIS C TESTING PRODUCTS
14.4.3.1. HCV ANTIBODY TESTS
14.4.3.1.1. MARKET VALUE (USD MILLION)
14.4.3.1.2. MARKET VOLUME (UNITS)
14.4.3.1.3. AVERAGE SELLING PRICE (USD)
14.4.3.2. HCV VIRAL LOAD TESTS
14.4.3.2.1. MARKET VALUE (USD MILLION)
14.4.3.2.2. MARKET VOLUME (UNITS)
14.4.3.2.3. AVERAGE SELLING PRICE (USD)
14.4.3.3. OTHER TESTS
14.4.4 SEXUALLY TRANSMITTED DISEASE (STD) TESTING
14.4.4.1. NAAT-BASED SYSTEMS
14.4.4.1.1. MARKET VALUE (USD MILLION)
14.4.4.1.2. MARKET VOLUME (UNITS)
14.4.4.1.3. AVERAGE SELLING PRICE (USD)
14.4.4.2. NON–NAAT-BASED SYSTEMS
14.4.4.2.1. MARKET VALUE (USD MILLION)
14.4.4.2.2. MARKET VOLUME (UNITS)
14.4.4.2.3. AVERAGE SELLING PRICE (USD)
14.4.5 HEALTHCARE-ASSOCIATED INFECTION (HAI) TESTING
14.4.5.1. MARKET VALUE (USD MILLION)
14.4.5.2. MARKET VOLUME (UNITS)
14.4.5.3. AVERAGE SELLING PRICE (USD)
14.4.6 RESPIRATORY INFECTION TESTING PRODUCTS
14.4.6.1. MARKET VALUE (USD MILLION)
14.4.6.2. MARKET VOLUME (UNITS)
14.4.6.3. AVERAGE SELLING PRICE (USD)
14.4.7 TROPICAL DISEASE TESTING PRODUCTS
14.4.7.1. MARKET VALUE (USD MILLION)
14.4.7.2. MARKET VOLUME (UNITS)
14.4.7.3. AVERAGE SELLING PRICE (USD)
14.4.8 COVID-19
14.4.8.1. MARKET VALUE (USD MILLION)
14.4.8.2. MARKET VOLUME (UNITS)
14.4.8.3. AVERAGE SELLING PRICE (USD)
14.4.9 OTHER INFECTIOUS DISEASE TESTING PRODUCTS
14.5 COAGULATION MONITORING PRODUCTS
14.5.1 ANTICOAGULATION MONITORING DEVICES
14.5.1.1. PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES
14.5.1.1.1. MARKET VALUE (USD MILLION)
14.5.1.1.2. MARKET VOLUME (UNITS)
14.5.1.1.3. AVERAGE SELLING PRICE (USD)
14.5.1.2. ACTIVATED CLOTTING TIME (ACT)
14.5.1.2.1. MARKET VALUE (USD MILLION)
14.5.1.2.2. MARKET VOLUME (UNITS)
14.5.1.2.3. AVERAGE SELLING PRICE (USD)
14.5.1.3. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)
14.5.1.3.1. MARKET VALUE (USD MILLION)
14.5.1.3.2. MARKET VOLUME (UNITS)
14.5.1.3.3. AVERAGE SELLING PRICE (USD)
14.5.2 PLATELET FUNCTION MONITORING DEVICES
14.5.2.1. MARKET VALUE (USD MILLION)
14.5.2.2. MARKET VOLUME (UNITS)
14.5.2.3. AVERAGE SELLING PRICE (USD)
14.5.3 VISCOELASTIC COAGULATION MONITORING DEVICES
14.5.3.1. THROMBOELASTOGRAPHY (TEG)
14.5.3.1.1. MARKET VALUE (USD MILLION)
14.5.3.1.2. MARKET VOLUME (UNITS)
14.5.3.1.3. AVERAGE SELLING PRICE (USD)
14.5.3.2. ROTATIONAL THROMBOELASTOMETRY (ROTEM)
14.5.3.2.1. MARKET VALUE (USD MILLION)
14.5.3.2.2. MARKET VOLUME (UNITS)
14.5.3.2.3. AVERAGE SELLING PRICE (USD)
14.5.4 OTHERS
14.6 PREGNANCY & FERTILITY TESTING PRODUCTS
14.6.1 PREGNANCY TESTING PRODUCTS
14.6.1.1. PREGNANCY TESTING , BY PRODUCT TYPE
14.6.1.1.1. STRIPS/ DIP STICKS AND CARDS
14.6.1.1.1.1 MARKET VALUE (USD MILLION)
14.6.1.1.1.2 MARKET VOLUME (UNITS)
14.6.1.1.1.3 AVERAGE SELLING PRICE (USD)
14.6.1.1.2. MID STREAM DEVICES
14.6.1.1.2.1 MARKET VALUE (USD MILLION)
14.6.1.1.2.2 MARKET VOLUME (UNITS)
14.6.1.1.2.3 AVERAGE SELLING PRICE (USD)
14.6.1.1.3. CASSETTES
14.6.1.1.3.1 MARKET VALUE (USD MILLION)
14.6.1.1.3.2 MARKET VOLUME (UNITS)
14.6.1.1.3.3 AVERAGE SELLING PRICE (USD)
14.6.1.1.4. DIGITAL DEVICES
14.6.1.1.4.1 MARKET VALUE (USD MILLION)
14.6.1.1.4.2 MARKET VOLUME (UNITS)
14.6.1.1.4.3 AVERAGE SELLING PRICE (USD)
14.6.1.1.5. LINE-INDICATOR DEVICES
14.6.1.1.5.1 MARKET VALUE (USD MILLION)
14.6.1.1.5.2 MARKET VOLUME (UNITS)
14.6.1.1.5.3 AVERAGE SELLING PRICE (USD)
14.6.1.2. PREGNANCY TESTING, BY TEST TYPE
14.6.1.2.1. FSH URINE TEST
14.6.1.2.1.1 MARKET VALUE (USD MILLION)
14.6.1.2.1.2 MARKET VOLUME (UNITS)
14.6.1.2.1.3 AVERAGE SELLING PRICE (USD)
14.6.1.2.2. LUTEINIZING HORMONE (LH) URINE TEST
14.6.1.2.2.1 MARKET VALUE (USD MILLION)
14.6.1.2.2.2 MARKET VOLUME (UNITS)
14.6.1.2.2.3 AVERAGE SELLING PRICE (USD)
14.6.1.2.3. HUMAN CHORIONIC GONADOTROPIN (HCG) BLOOD/SERUM TEST
14.6.1.2.3.1 MARKET VALUE (USD MILLION)
14.6.1.2.3.2 MARKET VOLUME (UNITS)
14.6.1.2.3.3 AVERAGE SELLING PRICE (USD)
14.6.1.2.4. HCG URINE TEST
14.6.1.2.4.1 MARKET VALUE (USD MILLION)
14.6.1.2.4.2 MARKET VOLUME (UNITS)
14.6.1.2.4.3 AVERAGE SELLING PRICE (USD)
14.6.2 FERTILITY TESTING PRODUCTS
14.6.2.1. HUMAN CHORIONIC GONADOTROPIN (HCG) URINE TEST
14.6.2.1.1. MARKET VALUE (USD MILLION)
14.6.2.1.2. MARKET VOLUME (UNITS)
14.6.2.1.3. AVERAGE SELLING PRICE (USD)
14.6.2.2. FSH URINE TEST
14.6.2.2.1. MARKET VALUE (USD MILLION)
14.6.2.2.2. MARKET VOLUME (UNITS)
14.6.2.2.3. AVERAGE SELLING PRICE (USD)
14.6.2.3. HUMAN CHORIONIC GONADOTROPIN (HCG) BLOOD TEST
14.6.2.3.1. MARKET VALUE (USD MILLION)
14.6.2.3.2. MARKET VOLUME (UNITS)
14.6.2.3.3. AVERAGE SELLING PRICE (USD)
14.6.2.4. LUTEINIZING HORMONE (LH) URINE TEST
14.6.2.4.1. MARKET VALUE (USD MILLION)
14.6.2.4.2. MARKET VOLUME (UNITS)
14.6.2.4.3. AVERAGE SELLING PRICE (USD)
14.7 TUMOR/CANCER MARKER TESTING PRODUCTS
14.7.1 MARKET VALUE (USD MILLION)
14.7.2 MARKET VOLUME (UNITS)
14.7.3 AVERAGE SELLING PRICE (USD)
14.8 URINALYSIS TESTING PRODUCTS
14.8.1 POC URINE STRIP SELF-TESTING
14.8.1.1. MARKET VALUE (USD MILLION)
14.8.1.2. MARKET VOLUME (UNITS)
14.8.1.3. AVERAGE SELLING PRICE (USD)
14.8.2 POC URINE TEST STRIP PROFESSIONAL TESTING
14.8.2.1. MARKET VALUE (USD MILLION)
14.8.2.2. MARKET VOLUME (UNITS)
14.8.2.3. AVERAGE SELLING PRICE (USD)
14.9 CHOLESTEROL TESTING PRODUCTS
14.9.1 INSTRUMENTS
14.9.1.1. TABLE-TOP ANALYZERS
14.9.1.1.1. MARKET VALUE (USD MILLION)
14.9.1.1.2. MARKET VOLUME (UNITS)
14.9.1.1.3. AVERAGE SELLING PRICE (USD)
14.9.1.2. HAND-HELD ANALYZERS
14.9.1.2.1. MARKET VALUE (USD MILLION)
14.9.1.2.2. MARKET VOLUME (UNITS)
14.9.1.2.3. AVERAGE SELLING PRICE (USD)
14.9.2 TESTING KITS
14.9.2.1. MARKET VALUE (USD MILLION)
14.9.2.2. MARKET VOLUME (UNITS)
14.9.2.3. AVERAGE SELLING PRICE (USD)
14.1 HEMATOLOGY TESTING PRODUCTS
14.10.1 MARKET VALUE (USD MILLION)
14.10.2 MARKET VOLUME (UNITS)
14.10.3 AVERAGE SELLING PRICE (USD)
14.11 DRUGS-OF-ABUSE (DOA) TESTING PRODUCTS
14.11.1 DOA ANALYSERS
14.11.1.1. IMMUNOASSAYS
14.11.1.1.1. MARKET VALUE (USD MILLION)
14.11.1.1.2. MARKET VOLUME (UNITS)
14.11.1.1.3. AVERAGE SELLING PRICE (USD)
14.11.1.2. CHROMATOGRAPHIC DEVICES
14.11.1.2.1. MARKET VALUE (USD MILLION)
14.11.1.2.2. MARKET VOLUME (UNITS)
14.11.1.2.3. AVERAGE SELLING PRICE (USD)
14.11.1.3. BREATH ANALYSERS
14.11.1.3.1. MARKET VALUE (USD MILLION)
14.11.1.3.2. MARKET VOLUME (UNITS)
14.11.1.3.3. AVERAGE SELLING PRICE (USD)
14.11.2 RAPID TESTING DEVICES
14.11.2.1. URINE TESTING DEVICES
14.11.2.1.1. MARKET VALUE (USD MILLION)
14.11.2.1.2. MARKET VOLUME (UNITS)
14.11.2.1.3. AVERAGE SELLING PRICE (USD)
14.11.2.2. ORAL FLUID TESTING DEVICES
14.11.2.2.1. MARKET VALUE (USD MILLION)
14.11.2.2.2. MARKET VOLUME (UNITS)
14.11.2.2.3. AVERAGE SELLING PRICE (USD)
14.11.3 OTHERS
14.12 FECAL OCCULT TESTING PRODUCTS
14.12.1 GUAIAC FOB STOOL TEST
14.12.1.1. MARKET VALUE (USD MILLION)
14.12.1.2. MARKET VOLUME (UNITS)
14.12.1.3. AVERAGE SELLING PRICE (USD)
14.12.2 IMMUNO-FOB AGGLUTINATION TEST
14.12.2.1. MARKET VALUE (USD MILLION)
14.12.2.2. MARKET VOLUME (UNITS)
14.12.2.3. AVERAGE SELLING PRICE (USD)
14.12.3 LATERAL FLOW IMMUNO-FOB TEST
14.12.3.1. MARKET VALUE (USD MILLION)
14.12.3.2. MARKET VOLUME (UNITS)
14.12.3.3. AVERAGE SELLING PRICE (USD)
14.12.4 IMMUNO-FOB ELISA TEST
14.12.4.1. MARKET VALUE (USD MILLION)
14.12.4.2. MARKET VOLUME (UNITS)
14.12.4.3. AVERAGE SELLING PRICE (USD)
14.13 OTHER POC PRODUCTS
15 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , BY APPLICATION
15.1 OVERVIEW
15.2 BLOOD TRANSFUSION
15.3 CARDIAC MONITORING
15.4 COAGULATION
15.5 BLOOD GLUCOSE
15.6 HAEMATOLOGY
15.7 NON- INVASIVE SPO2 MONITORING
15.8 NON- INVASIVE PCO2 MONITORING
15.9 WHOLE BLOOD ANALYSIS
15.1 VITAL SIGN MONITORING
15.11 OTHERS
16 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , BY PLATFORM
16.1 OVERVIEW
16.2 LATERAL FLOW ASSAYS
16.3 IMMUNOCHROMATOGRAPHY TESTS
16.4 DIPSTICKS
16.5 MICROFLUIDICS
16.6 MOLECULAR DIAGNOSTICS
16.7 IMMUNOASSAYS
16.8 CLINICAL CHEMISTRY ASSAYS
16.9 HEMATOLOGY
16.1 OTHERS
17 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , BY PRESCRIPTION MODE
17.1 OVERVIEW
17.2 PRESCRIPTION-BASED TESTING
17.3 OTC TESTING
18 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , BY TESTING LOCATION
18.1 OVERVIEW
18.2 LABORATORY BASED POINT-OF-CARE-TESTING (POCT)
18.3 AT-HOME POINT-OF-CARE-TESTING (POCT)
19 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , BY END USER
19.1 OVERVIEW
19.2 HOSPITAL
19.2.1 PRIVATE
19.2.1.1. TIER 1
19.2.1.2. TIER 2
19.2.1.3. TIER 3
19.2.2 PUBLIC
19.2.2.1. TIER 1
19.2.2.2. TIER 2
19.2.2.3. TIER 3
19.3 CLINICS
19.4 LABORATORIES
19.5 PATHOLOGY LABS
19.6 DIAGNOSTIC CENTER
19.7 HOME CARE
19.8 AMBULATORY SURGERY CENTERS
19.9 ELDERLY CARE CENTERS
19.1 OTHERS
20 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , BY DISTRIBUTION CHANNEL
20.1 OVERVIEW
20.2 DIRECT TENDER
20.3 RETAIL SALES
20.4 ONLINE SALES
20.5 OTHERS
21 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , SWOT AND DBMR ANALYSIS
22 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , COMPANY LANDSCAPE
22.1 COMPANY SHARE ANALYSIS: THAILAND
22.2 MERGERS & ACQUISITIONS
22.3 NEW PRODUCT DEVELOPMENT & APPROVALS
22.4 EXPANSIONS
22.5 REGULATORY CHANGES
22.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
23 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , BY REGION
Thailand Point-of-Care-Testing (POCT) Market , (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
23.1 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
24 THAILAND POINT-OF-CARE-TESTING (POCT) MARKET , COMPANY PROFILE
24.1 F. HOFFMANN-LA ROCHE LTD
24.1.1 COMPANY OVERVIEW
24.1.2 REVENUE ANALYSIS
24.1.3 GEOGRAPHIC PRESENCE
24.1.4 PRODUCT PORTFOLIO
24.1.5 RECENT DEVELOPMENTS
24.2 SIEMENS HEALTHCARE GMBH
24.2.1 COMPANY OVERVIEW
24.2.2 REVENUE ANALYSIS
24.2.3 GEOGRAPHIC PRESENCE
24.2.4 PRODUCT PORTFOLIO
24.2.5 RECENT DEVELOPMENTS
24.3 ABBOTT
24.3.1 COMPANY OVERVIEW
24.3.2 REVENUE ANALYSIS
24.3.3 GEOGRAPHIC PRESENCE
24.3.4 PRODUCT PORTFOLIO
24.3.5 RECENT DEVELOPMENTS
24.4 BIOMÉRIEUX
24.4.1 COMPANY OVERVIEW
24.4.2 REVENUE ANALYSIS
24.4.3 GEOGRAPHIC PRESENCE
24.4.4 PRODUCT PORTFOLIO
24.4.5 RECENT DEVELOPMENTS
24.5 ACON LABORATORIES, INC.
24.5.1 COMPANY OVERVIEW
24.5.2 REVENUE ANALYSIS
24.5.3 GEOGRAPHIC PRESENCE
24.5.4 PRODUCT PORTFOLIO
24.5.5 RECENT DEVELOPMENTS
24.6 BIO-RAD LABORATORIES, INC
24.6.1 COMPANY OVERVIEW
24.6.2 REVENUE ANALYSIS
24.6.3 GEOGRAPHIC PRESENCE
24.6.4 PRODUCT PORTFOLIO
24.6.5 RECENT DEVELOPMENTS
24.7 WERFEN
24.7.1 COMPANY OVERVIEW
24.7.2 REVENUE ANALYSIS
24.7.3 GEOGRAPHIC PRESENCE
24.7.4 PRODUCT PORTFOLIO
24.7.5 RECENT DEVELOPMENTS
24.8 NOVA BIOMEDICAL
24.8.1 COMPANY OVERVIEW
24.8.2 REVENUE ANALYSIS
24.8.3 GEOGRAPHIC PRESENCE
24.8.4 PRODUCT PORTFOLIO
24.8.5 RECENT DEVELOPMENTS
24.9 PTS DIAGNOSTICS
24.9.1 COMPANY OVERVIEW
24.9.2 REVENUE ANALYSIS
24.9.3 GEOGRAPHIC PRESENCE
24.9.4 PRODUCT PORTFOLIO
24.9.5 RECENT DEVELOPMENTS
24.1 SEKISUI DIAGNOSTICS
24.10.1 COMPANY OVERVIEW
24.10.2 REVENUE ANALYSIS
24.10.3 GEOGRAPHIC PRESENCE
24.10.4 PRODUCT PORTFOLIO
24.10.5 RECENT DEVELOPMENTS
24.11 TRINITY BIOTECH
24.11.1 COMPANY OVERVIEW
24.11.2 REVENUE ANALYSIS
24.11.3 GEOGRAPHIC PRESENCE
24.11.4 PRODUCT PORTFOLIO
24.11.5 RECENT DEVELOPMENTS
24.12 DANAHER
24.12.1 COMPANY OVERVIEW
24.12.2 REVENUE ANALYSIS
24.12.3 GEOGRAPHIC PRESENCE
24.12.4 PRODUCT PORTFOLIO
24.12.5 RECENT DEVELOPMENTS
24.13 THERMO FISHER SCIENTIFIC INC
24.13.1 COMPANY OVERVIEW
24.13.2 REVENUE ANALYSIS
24.13.3 GEOGRAPHIC PRESENCE
24.13.4 PRODUCT PORTFOLIO
24.13.5 RECENT DEVELOPMENTS
24.14 MERIDIAN DIAGNOSTICS
24.14.1 COMPANY OVERVIEW
24.14.2 REVENUE ANALYSIS
24.14.3 GEOGRAPHIC PRESENCE
24.14.4 PRODUCT PORTFOLIO
24.14.5 RECENT DEVELOPMENTS
24.15 BD
24.15.1 COMPANY OVERVIEW
24.15.2 REVENUE ANALYSIS
24.15.3 GEOGRAPHIC PRESENCE
24.15.4 PRODUCT PORTFOLIO
24.15.5 RECENT DEVELOPMENTS
24.16 SYSMEX (THAILAND) CO., LTD
24.16.1 COMPANY OVERVIEW
24.16.2 REVENUE ANALYSIS
24.16.3 GEOGRAPHIC PRESENCE
24.16.4 PRODUCT PORTFOLIO
24.16.5 RECENT DEVELOPMENTS
24.17 FUJIFILM THAILAND LTD.
24.17.1 COMPANY OVERVIEW
24.17.2 REVENUE ANALYSIS
24.17.3 GEOGRAPHIC PRESENCE
24.17.4 PRODUCT PORTFOLIO
24.17.5 RECENT DEVELOPMENTS
25 RELATED REPORTS
26 CONCLUSION
27 QUESTIONNAIRE
28 ABOUT DATA BRIDGE MARKET RESEARCH
